Ignite Creation Date:
2024-05-05 @ 4:43 PM
Last Modification Date:
2024-10-26 @ 9:23 AM
Study NCT ID:
NCT00307723
Status:
TERMINATED
Last Update Posted:
2009-08-10
First Post:
2006-03-24
Brief Title:
Study of Bevacizumab in Combination With 5-FU Oxaliplatin and External Beam Radiation Followed by Gemcitabine and Bevacizumab for Locally Advanced Pancreatic Cancer
Sponsor:
Massachusetts General Hospital
Organization:
Massachusetts General Hospital
Organization Data
Organization:
Massachusetts General Hospital
Class:
OTHER
Study ID:
05-233
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Massachusetts General Hospital
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Lawrence Blaszkowsky MD
Old Organization:
Massachusetts General Hospital
Collaborators
| Name | Class |
|---|---|
| Sanofi | INDUSTRY |
| Dana-Farber Cancer Institute | OTHER |
| Beth Israel Deaconess Medical Center | OTHER |
| Genentech Inc | INDUSTRY |